Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

LGVN

LGVN News

Newswire

09:23

Longeveron Executives to Speak at Global CardioVascular Clinical Trialists Forum.

09:21

Longeveron Announces Positive Results for Aging-Related Frailty Therapy

08:16

Longeveron shares rise 11.11% premarket after Phase 2 trial reveals laromestrocel reduces hippocampal neuroinflammation in Alzheimer’s.

06:31

Longeveron shares jump 13.05% premarket as Alzheimer's treatment data selected for CTAD 2025 poster presentation.

09:20

Longeveron's Alzheimer's Study Selected for Poster Presentation at CTAD 2025 Conference.

View More

About LGVN

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More